We enroll suppliers in our SSP SSP Supplier Sustainability Program based on a number of risk metrics as well as the size of their business with us. The SSP requires, among other things, suppliers to conform to our Responsibility Standards for Suppliers, and all suppliers in the program regularly complete an assessment by EcoVadis, a recognized provider of business sustainability ratings for global supply chains. See section on Responsible Supply Base for details on our progress toward our Supplier Sustainability Program 2025 Goal.
For us, sustainability spans a wide range of opportunities: economic, social and environment. In order to have the long-lasting, positive impact that all of our stakeholders deserve, we work closely with our global supplier community to amplify and expand our reach. Together, we can accomplish so much for our collective future.
As part of our own commitment to reduce our Scope 3 emissions, the CDP Supply Chain program is another part of the SSP that requires our suppliers to be transparent about their supply chain impacts by publicly disclosing to CDP their environmental performance, including GHG GHG Greenhouse gas or gases emissions and water use. We make this a requirement of our largest emitting suppliers in the program, and the strong participation of our suppliers earned recognition for Johnson & Johnson in 2021, when we were named to the CDP Supplier Engagement leader board for the fifth consecutive year.
82% of invited suppliers participated in the CDP Supply Chain Climate Program, and 75% of invited suppliers participated in the CDP Supply Chain Water Program.
Auditing supplier site compliance: We verify supplier site compliance with laws and regulations as well as with other policies, including our Responsibility Standards for Suppliers and our Position on Human Rights, through our EH&S EH&S Environmental Health & Safety audit program and SSP. Our EH&S audit program, which has been in place since 2006, is conducted using the audit protocol and checklist developed by the Pharmaceutical Supply Chain Initiative (PSCI). Our social audits program, part of our SSP, is conducted in accordance with Supplier Ethical Data Exchange (Sedex) Members Ethical Trade Audit (SMETA) 4-Pillar guidelines and is focused on human and labor rights. In 2021, we completed 124 EH&S audits, the majority in Asia, and 11 social audits. Our audit programs in 2021 continued to be affected by COVID-19, mostly due to travel restrictions, minimizing in-person site visits and limited resources at suppliers to support audits. We continued to leverage virtual audits using video and other online tools.
Building supplier capabilities through our SSP: In 2021, we launched our Onward Sustainability Program, part of our SSP, to focus on direct engagement with suppliers to explain our requirements and how they can best meet them. Replacing our previous static supplier toolkit, Onward is an engaging and broad-reaching series of webinars and materials in which Johnson & Johnson's procurement and sustainability subject matter experts partner with the British Standards Institution to host best-practice sharing sessions on topics relating to our goals and objectives. The program is ongoing but has included sessions on sustainability basics, starting a supplier sustainability program and how to host an audit. The live sessions and materials directly reach more than 1,000 suppliers in our SSP and are available anytime to all our suppliers in our Supplier Quality Academy. In 2021, we delivered five Onward Sustainability Program sessions, in which more than 1,000 attendees from 45 different countries participated.
Engaging suppliers in innovation: Johnson & Johnson has created a Supplier-Enabled Innovation Program that allows us to generate innovative solutions from our supply base to solve our greatest business challenges to profoundly change the trajectory of health for humanity. We have created processes to spark innovation from our supply base, both through our Supplier Management Program and by posting a challenge in our supplier-enabled innovation technology platform. In early 2021, the Johnson & Johnson Procurement organization held its first-ever Supplier-Enabled Innovation Awards event, recognizing the top innovations from these programs in 2020. Partners recognized in our awards program for their top innovations include:
- A biotechnology company that helped us incorporate a plant-derived material in our COVID-19 vaccine production, resulting in increased manufacturing volumes and other improvements;
- Our clinical trial network to improve enrollment of diverse patients in clinical trials through use of novel data science approaches that identify outbreak hot spots and encourage trial participation, especially with difficult-to-enroll minority populations; and
- A supplier to create a first-to-market recycling solution for single-use medical devices, enabling safe reuse of tons of materials that would otherwise have been incinerated or landfilled.
The awards program will be conducted annually to continue to recognize and celebrate the top Supplier-Enabled Innovations.
Surveying clinical trial partners: External clinical trial partners are a crucial link in our drug development process and play an important role in partnering with Johnson & Johnson to increase patient diversity in our clinical trials. This year, we conducted a survey covering 12 clinical suppliers spanning nine service categories to better understand the expertise, performance and behaviors across our partnerships. With insights from the survey, which received hundreds of responses, we are able to lead productive conversations, strengthen our relationships and reinforce targeted improvements in the design and execution of our clinical studies, with a particular focus on increasing patient diversity.
Partnerships for Good: As one of our Health for Humanity 2025 Goals, in June 2020, in solidarity with the Association of National Advertisers and the Alliance for Inclusive and Multicultural Marketing, Johnson & Johnson signed a petition holding ourselves accountable to aggressively pursue equity in advertising and marketing. We collaborated with three agency holding companies and global media partners to adopt microcharters that support our DEI DEI Diversity, equity and inclusion objectives. DEI metrics are now included in our agencies’ year-end evaluations, and pay-for-performance compensation models measure and reward the impact of our efforts. Over the past year, with our agency partners, we introduced training and updated hiring practices and equitable content creation at each organization, helping drive better representation of consumers and supporting growth for diverse businesses. Overall, our diverse media spend increased in 2021. Additionally in 2021, we confirmed a collaboration with American Express Global Business Travel to develop a training for business travelers to explain how to spot and report potential instances of human trafficking. See section on Responsible Supply Base for details on our progress towards our Partnerships for Good 2025 Goal.